Next Article in Journal
Transient Complete Nodal Atrioventricular Block and Left Bundle Branch Block During Radiofrequency Catheter Ablation of a Left Free Wall Accessory Pathway
Previous Article in Journal
Kardiales Papilläres Fibroelastom
 
 
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Die Behandlung der Karotisstenose aus der Sicht des Interventionalisten

Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland
*
Author to whom correspondence should be addressed.
Cardiovasc. Med. 2005, 8(9), 306; https://doi.org/10.4414/cvm.2005.01121
Submission received: 30 June 2005 / Revised: 30 July 2005 / Accepted: 30 August 2005 / Published: 30 September 2005

Abstract

In the hand of experienced interventionalists carotid stenting is a valuable alternative to endarterectomy for patients with carotid stenosis. Mechanical emboli-protection systems have been a major advance in the field by reducing the incidence of periprocedural neurologic events. The greatest advantage of carotid stenting over endarterectomy is that the outcomes are far less influenced by the comorbidities of the patients. Therefore, the endovascular treatment of carotid disease is particularly suitable for patients at high-risk for surgery. The SAPPHIRE study, which randomised patients at high-risk for surgery to endarterectomy or carotid stenting with filter-emboli protection, demonstrated that patients allocated to carotid stenting had significantly less adverse events. Advantages of carotid stenting over endarterectomy include the reduction of periprocedural myocardial infarctions, the lack of general anesthesia and of neck complications such as cranial nerve lesions. In addition, patients are generally discharged the day following stenting, which leads to a reduction in costs. Patients particularly suitable for carotid stenting are elderly (≥75 years of age), with restenosis following surgery, with stenosis/ occlusion of the contralateral carotid, and those requiring coronary bypass surgery. The only large-scale randomised trial published in non-high risk patients (CAVATAS) showed similar results in patients treated surgically or with balloon angioplasty. The results of ongoing trials should be awaited before expanding the indication of carotid stenting to this patient population off-protocol and in non-specialised centers.

Share and Cite

MDPI and ACS Style

Roffi, M.; Eberli, F.R. Die Behandlung der Karotisstenose aus der Sicht des Interventionalisten. Cardiovasc. Med. 2005, 8, 306. https://doi.org/10.4414/cvm.2005.01121

AMA Style

Roffi M, Eberli FR. Die Behandlung der Karotisstenose aus der Sicht des Interventionalisten. Cardiovascular Medicine. 2005; 8(9):306. https://doi.org/10.4414/cvm.2005.01121

Chicago/Turabian Style

Roffi, Marco, and Franz R. Eberli. 2005. "Die Behandlung der Karotisstenose aus der Sicht des Interventionalisten" Cardiovascular Medicine 8, no. 9: 306. https://doi.org/10.4414/cvm.2005.01121

APA Style

Roffi, M., & Eberli, F. R. (2005). Die Behandlung der Karotisstenose aus der Sicht des Interventionalisten. Cardiovascular Medicine, 8(9), 306. https://doi.org/10.4414/cvm.2005.01121

Article Metrics

Back to TopTop